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Peripheral and Central Arterial Haemodynamic Interactions are Early
Abnormalities in Young Male Cigarette Smokers
F. Fennessy, R. G. Casey and D. Bouchier-Hayes
Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
Background: smoking, result in endothelial dysfunction and this affects systemic and local haemodynamics. The aim was
to assess interactions of the left ventricle and arterial system of smokers at baseline and after a physiological stimulus ± the
cold pressor test (CPT) which causes a sympathetically driven vasoconstriction that counteracts the normal endothelial
dependent vasodilatation.
Materials and Methods: male smokers and controls were compared using applanation tonometry. Parameters included
systolic and diastolic blood pressure, ejection duration, heart rate, aortic augmentation index (AAI), and sub-endocardial
viability ratio (SEVR). The CPT was performed at 1 and 3 min following immersion of the hand in ice.
Results: smokers have abnormal baseline cardiac timing (heart rate and ejection duration), systolic and diastolic blood
pressures which are due to increased peripheral wave reflection (AAI) and thus affect the SEVR. Following CPT, the
pressure wave differential, dP/dt, was significantly increased in smokers compared to non-smokers who had a decrease at
1 min in ice. Mean systolic and diastolic pressure was significantly increased in both groups at 1 and 3 min as was end
systolic pressure in non-smokers.
Conclusions: baseline ventriculo-vascular dynamics, are abnormal as was the evoked response to CPT. The blunted blood
pressure increase of smokers compared to controls following CPT, may represent altered nitric oxide production in the
macro and microcirculation through differential upregulation of endothelial nitric oxide synthase (eNOS) and inducible
NOS respectively. The potential for therapeutic intervention and prevention of ongoing endothelial injury, requires further
investigation.
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The importance of the endothelium in regulating vas-
cular tone, by modulating vascular smooth muscle
activity, was pioneered by Furchgott and Zawadzki.1
The presence of intact, functional endothelium main-
tains blood flow, and by controlling smooth muscle
activity has a major role in determining vascular
diameter and peripheral vascular resistance. The endo-
thelium has a dynamic nature due in part to the
ever-changing haemodynamic environment to which
it must respond. The response to physiological stress
(such as the cold pressor test) in turn influ-
ences the haemodynamic interactions of the whole
cardiovascular system.
The evaluation of ventriculo-vascular interactions
has been reported in the literature in recent years
using arterial applanation tonometry (sphygmocar-
diography) (PWV Medical Blood Pressure Analysis Please address all correspondence to: R. G. Casey, Surgical Research
Department, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.
1078±5884/03/020152 07 $35.00/0 # 2003 Elsevier Science Ltd. AlSystem, Sydney). It permits evaluation of the dynamic
interaction of the left ventricle and the arterial system
by analysis of the peripheral pressure waveform. This
technique is not used routinely in clinical practice yet
as the main role is the early assessment of pre-clinical
vascular dysfunction and possible prophylactic/
therapeutic intervention in order to prevent the ather-
ogenesis. When the heart beats it causes blood flow in
the arterial tree in a pulsatile manner. When blood
flow meets peripheral resistance it is reflected back
towards the heart. In the young and healthy this
occurs in cardiac diastole thus increasing central dia-
stolic pressure and aiding coronary artery perfusion.
However, in the presence of stiffened, poorly compli-
ant vessels or microvascular peripheral resistance
such as might occur in smoking, diabetes, hyperten-
sion or ageing, this wave is reflected back to the heart
earlier during cardiac systole. This is termed `` aug-
mentation'' and reflects arterial stiffness and increased
pulse wave velocity. It results in increased central
systolic blood pressure which is a strong independent
predictor of hypertension, ischaemic heart diseasel rights reserved.
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invasive bedside haemodynamic assessment and is a
well-described technique5±8 that has been validated
against invasive blood pressure monitoring techni-
ques.9 Using generalised transfer functions (a constant
relationship between pressure waves at different sites)
the ascending aortic pressure waveform is derived
and the effect of vasoactive and physiological stimuli
on central arterial parameters can be evaluated.10,11
The aortic augmentation index (AAI) is a measure of
the actual pulse pressure in relation to what the pulse
pressure would be if there was no augmentation from
reflected waves. For example, if the AAI is 4100%,
the reflected waveform is larger than the primary
waveform. It is calculated from the formula
AAIP(T2)ÿP(T0)/P(T1)ÿP(T0)6 100% where;
P(T0)pressure at the foot of the pulse (indicating
onset of ventricular ejection);
P(T1)pressure at the first shoulder of the pulse wave
(End of systole);
P(T2)pressure at the second shoulder of the pulse
wave (often constitutes peak pressure in the
elderly due to reflected wave reaching ventricle
during systole).
The Buckberg index,12,13 also termed the sub-
endocardial viability ratio (SEVR) is a measure of the
propensity to cardiac ischaemia due to shortened dia-
stole or lengthened systole. It is calculated according
to the formula:
(Diastolic timePressure)
/(Systolic timePressure 100.
The cold pressor test, first described over 60 years
ago14 has been used as a model of systemic physio-
logical stress on the cardiovascular system.15±17 Cold
stress elicits a-adrenergic vasoconstriction and
pressor responses due to smooth muscle contraction.
However, the early dysfunctional endothelium that
occurs in smokers, and which pre-dates atheromatous
disease, likely impairs endothelial nitric oxide (NO) or
other dilator substances that counteract the vasocon-
strictor responses. This effect is seen in diseased epi-
cardial arteries exposed to cold. Therefore, endothelial
dysfunction may result in loss of normal smooth mus-
cle dilator function and permit reduced dilation or
constriction to various stimuli. This is due to reduced
sympathetic-induced NO production, either through
failure of a sympathetic induced increase in blood
flow (and thus flow mediated endothelial dependent
dilatation due to NO release) or failure in a2 endothe-
lial receptor stimulation (which stimulates NO
release).18,19 This prevents endothelial NO releaseovercoming adrenergic-induced vasoconstrictor
effects of the CPT on smooth muscle thus leading to
vasoconstriction. This effect differs depending on
which vascular bed is studied. A number of studies
have demonstrated that the cardiovascular responses
to the CPT predicts future blood pressure and the
development of hypertension.20±22
The effect of the CPT on the ventriculo-vascular
interactions in smokers is unknown and thus the aim
of this study was to examine interactions at baseline
and following CPT.
Materials and Methods
Subjects
Eight smokers and 11 lifelong non-smoking controls
aged 20±29 years of age were recruited from family
and friends. All subjects were normotensive, non-
diabetic and without a history of hyperlipidaemia or
a family history of premature vascular disease. They
were clinically well and not taking any cardiovascular
medications. Smokers were defined as those who
smoked at least 20 cigarettes per day for at least
2 years (2 pack year) and had at least one cigarette in
the preceding 12 h. They had not taken any caffeine
containing drinks for 12 h prior to the study. Control
subjects were life-long smokers. All smokers and con-
trol subjects were not taking regular exercise and had
sedentary occupations. All abstained from exercise
for 24 h prior to the study. Local ethics committee
approval was obtained for this study.
Study protocol
Applanation tonometry was conducted in a quiet,
temperature controlled room with subjects resting for
10 min prior to the baseline scan. The measurements
were taken at the same in the morning between 10.30
and midday. Blood pressure was measured by auscul-
tation over the left brachial artery using a standard
mercury sphygmomanometer, with diastolic pressure
defined as Korotkoff phase V according to American
Heart Association guidelines.23
Baseline peripheral and central haemodynamic
parameters were obtained by applanating the right
radial artery. After a baseline scan was performed
the right hand and wrist were immersed in a bath
of ice water for 3 min and then withdrawn.16 Blood
pressure measurements were taken prior to each
tonometric recording, which were taken at 1 and
3 min in ice.Eur J Vasc Endovasc Surg Vol 25, February 2003
Table 1. Demographic and clinical parameters for smokers and
control subjects.
Male smokers Controls p value
Number 8 11
Age (years) 24 (+4) 25 (+4) NS
Height (m) 1.7 (+0.3) 1.6 (+0.3) NS
Weight (kg) 74 (+10) 72 (+8)
NSnon-significant.
154 F. Fennessy et al.Measurement of arterial waveforms by
applanation tonometry
Pulse pressure waveform and amplitude were
obtained with a probe that incorporates a high fidelity
strain gauge transducer (Model TCB-500, Millar
Instruments). Pulse waves were obtained by placing
the pencil type probe perpendicularly over the point
of strongest pulsation of the radial artery. The sensor
is used to flatten the arterial wall against a bony sur-
face, tangential pressures are eliminated, and the sen-
sor is exposed to the true intra-arterial pressure. This
has been shown to be virtually identical to those mea-
sured invasively.8,24 The relationship between pres-
sure waves at peripheral and central arterial sites is
expressed as a `` transfer function'' and is incorporated
in a software programme.25
The wrist was held dorsiflexed using a support and
the probe was applied with steady pressure until a
good waveform signal appears wholly within the dis-
play. A good waveform was defined as one that was
consistent, large (at least 3 cm on screen) and in a
steady horizontal position. Twenty consecutive pres-
sure waveforms were recorded, averaged24 and peri-
pheral parameters such as dP/dt, the differential of
the pressure wave, were obtained. The applanation
tonometer has `` quality control'' software included.
When 20 waveforms are analysed the pulse height
variability (PHV) is calculated. This is a percentage
of mean pulse height (difference between maximum
and minimum of each pulse). The PHV parameter
gives a numerical value and will increase with beat-
to-beat pulse height variations ± typically as a result of
poor quality signals.
Diastolic variability is the averaged variability of
the diastolic points (minimums) from the mean dia-
stolic as a percentage of the pulse height. It increases
with beat-to-beat variations of the minimums and is a
measure of how steadily the tonometer was held dur-
ing the measurements. (If the tonometer is held per-
fectly steady the PHV% and Diastolic variability is
zero. Values greater than 4% will not be recorded and
the software programme expects repeat measurements
to be made until they fall within 0±4% variability.)
With the use of the constant transfer function from
ascending aorta to the radial artery the aortic pressure
waveform and left ventricular function can be mea-
sured. The differential pressure wave (dP/dt) that is
measured from the radial artery can be used to measure
the amplitude of reflected peripheral waves from the
vascular tree. When compared to the central cardiac
impulse this gives the augmentation index. Left ven-
tricular properties such as ejection duration and heart
rate can be derived from the aortic pressure wave.Eur J Vasc Endovasc Surg Vol 25, February 2003This aortic wave can be subdivided into systolic and
diastolic components, and allows ventriculo-vascular
interactions at baseline and following stressors to be
calculated.
Statistical analysis
Statistical analysis for this pilot study was performed
with SPSS version 10 statistics package. All data was
normally distributed, as checked with a plot of the
cumulative frequency distribution against the cumu-
lative frequency distribution for the normal distribu-
tion for a small sample size. Descriptive statistics were
expressed as mean SD. The control and the smoking
group were compared using ANOVA and two-sample
t-test. Statistical significance was inferred at p5 0.05.
Results
Smokers and control subjects (Table 1)
Demographic profiles and clinical parameters for
smokers (n 8) and controls (n 11) are shown in
Table 1. There was no significant difference in any of
these factors in either group.
Baseline central haemodynamic parameters (Table 2)
Baseline heart rate was significantly higher in smokers
than non-smokers: 80.63 (+11.57) beats/min vs 59.1
(+11.35 beats/min): (Students 2-sample t-test,
p 0.001).
Likewise, ejection duration (time of the cardiac
cycle spent in systole) was significantly greater in the
smoking group: 41 (+5)% vs 32.5 (+5)% in the non-
smoking group: (Students 2-sample t-test, p5 0.002).
Indices of left ventricular load, mean and end systo-
lic pressures were significantly greater in the smoking
group. Mean systolic pressure was 103 (+8.6) mmHg
in smokers vs 94 (+7.5) mmHg in non-smoking
controls: (Students 2-sample t-test, p5 0.05). End
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non-smokers: 104 (+11) mmHg vs 91.2 (+7) mmHg:
(Students 2-sample t-test, p5 0.05).
Mean diastolic pressure was also significantly
higher in smokers than in non-smoking group:
89 (+9) mmHg vs 79 (+6) mmHg: (Students 2-sample
t-test, p5 0.05). Central augmentation index (AI) was
significantly greater in smokers than non-smokers
at baseline: 134 (+32)% vs 100 (+20)%: (Students 2-
sample t-test, p5 0.05).
The Buckberg Index (sub-endocardial viability ratio
(SEVR)), is significantly lower in smokers compared to
non-smokers at baseline: 131.5 (+28)% vs 189 (+4)%
(Students 2-sample t-test, p5 0.005).
Effect of the Cold Pressor Test (Table 3)
Peripheral haemodynamic parameters
In response to the CPT, dP/dt was significantly
decreased in non-smokers at 1 and 3 min in iced
water when compared to baseline levels: 549
(+92) mmHg/s and 549 (+99) mmHg/s, respectively,Table 3. CPT effect on central haemodynamics for smokers and cont
Smokers
Baseline 1 min 3 mi
Heart Rate (bpm) 81 (12) 80 (11) 79
Mean systolic BP (mmHg) 103 (8) 111 (9)  111
End systolic BP (mmHg) 104 (12) 111 (11) 112
Mean diastolic BP (mmHg) 90 (9) 98 (8)  99
Ejection duration ± % time
in systole (ms)
41 (5) 41 (4) 40
AAI (%) 136 (34) 134 (30) 136
SEVRatio (%) 129 (29) 134 (31) 124
Data presented as means SD. Analysis with two sample t-test. Statis
* p5 0.05 vs baseline for own group.
Table 2. Baseline central haemodynamic parameters for smokers
and control subjects.
Male
smokers
Controls p value
Number 8 11
Heart Rate (beats/min) 81 (12) 59 (11) 50.001
Mean systolic BP(mmHg) 103 (9) 94 (8) 50.05
End systolic BP (mmHg) 104 (11) 91 (7) 50.05
Mean diastolic BP (mmHg) 89 (9) 79 (6) 50.05
Ejection duration ± % time in
systole (ms)
41 (5) 32.5 (5) 50.002
Aortic augmentation index (%) 134 (32) 100 (20) 50.05
Subendocardial viability ratio (%) 132 (28) 189 (44) 50.005
Data presented as means SD. Analysis with two sample t-test.
Statistical significance at p5 0.05.vs 697 (+59) mmHg/s: (Fig. 1) (Students paired t-test,
p5 0.05). This phenomenon did not occur with smo-
kers in whom there was a non-significant increase in
dP/dt at 1 min in ice and no change at 3 min in ice: 658
(+88) mmHg/s and 594 (+99) mmHg/s, respectively,
vs 599 (+57) mmHg/s. However, when the degree of
change from baseline from 1 and 3 min in ice was
investigated, it was found that the direction of
response in smokers was opposite to that of non-
smokers, with smokers having a significant increase
in their dP/dt in comparison to non smokers who had
a decrease at 1 min in ice: 66 (+11) mmHg/s vs ÿ165
(+63) mmHg/s: (Fig. 1) (Students 2 sample t-test,
p5 0.005).
Central haemodynamic parameters
The CPT had no effect on central haemodynamic
timing parameters. There was no change in heart
rate or ejection duration in either subject group in
response to this stimulus (Table 3).
Indices of left ventricular load ± mean systolic pres-
sure and end systolic pressure ± were increased inrol subjects.
Controls p value
n Baseline 1 min 3 min
(13) 59 (14) 59 (19) 59 (15) NS
(7)  91 (5) 107 (16)  110 (18)  50.05
(9) 88 (6) 107 (18)  110 (18)  50.05
(8)  79 (9) 93 (12)  94 (12)  50.05
(5) 33 (6) 31 (8) 32 (6) NS
(17) 100 (20) 124 (32) 119 (25) NS
(22) 189 (55) 222 (90) 203 (61) NS
tical significance at p5 0.05. NS=non-significant.
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Fig. 1. Pressure wave differential (dP/dt) in response to the CPT
in smokers and controls. Data as mean SD. £ p5 0.05 vs control
baseline (Student's paired t-test). $ p5 0.05 vs smokers at 1 min
(2 sample t-test).
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Fig. 2. Mean systolic pressure in response to CPT in smokers and
controls. Data as mean SD. £ p5 0.05 vs baseline (Student's two
sample t-test).
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Fig. 3. End systolic pressure in response to CPT in smokers and
controls. Data as mean SD. £ p5 0.05 vs baseline (Student's two
sample t-test).
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Fig. 4. Mean diastolic pressure in response to CPT in smokers and
controls. Data as mean SD. £ P5 0.05 vs baseline (Student's two
sample t-test).
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response to the CPT.
In non-smokers the mean systolic pressure increased
from 91 (+5) mmHg at baseline to 107 (+16) mmHg
and 110 (+18) at 1 and 3 min in ice respectively.
(Students paired t-test, p5 0.05) and in smokers
from 103 (+8) mmHg at baseline to 111 (+9) mmHg
and 111 (+7) mmHg at 1 and 3 min in ice: (Fig. 2)
(Students paired t-test, p5 0.05).
End systolic pressure increased in both groups in
response to the CPT, but only significantly in
non-smokers: 88 (+6) mmHg at baseline vs 107
(+18) mmHg and 110 (+20) at 1 and 3 min in ice:
(Fig. 3) (Students paired t-test, p5 0.05).
Mean diastolic pressure was significantly increased
in both subject groups in response to the CPT. Smo-
kers increased from 90 (+9) mmHg at baseline to 98
(+8) mmHg and 99 (+8) mmHg, and non smokers
from 79 (+9) mmHg to 93 (+12) mmHg and 94
(+12) mmHg at 1 and 3 min respectively (Fig. 4)
(Students paired t-test, p5 0.05).
In response to the CPT, overall mean central blood
pressure changes increased at 1 min in ice by 18
(+19) mmHg in smokers and by 12 (+4) mmHg in
non-smokers, and at 3 min by 17 (+18) mmHg inEur J Vasc Endovasc Surg Vol 25, February 2003smokers and 11 (+6) mmHg in non-smokers. The CPT
had no effect on the AAI in smokers. In contrast, this
stress resulted in an increase in AAI in non-smokers at
1 and 3 min. However, these values failed to reach
statistical significance.
Non-smokers had a non-significant increase in
SEVR at 1 and 3 min in ice.
Discussion
This study confirms the finding that cigarette smoking
results in significant baseline alterations in the inter-
actions between the arterial system and the left ven-
tricle. The evoked response to a physiological stress
(CPT) is also abnormal.
Baseline peripheral and central haemodynamic
parameters
Heart rate is significantly higher in smokers as has
been previously demonstrated.26 It was of interest to
find that the ejection duration, or time for ventricular
systole, is also longer. It would appear that this plus
the higher heart rate reduces the time for diastolic
filling and coronary perfusion in smokers. This, in
turn, is reflected in the reduced sub-endocardial via-
bility ratio (SEVR), which is a measure of perfusion of
the coronary system.12
These abnormal timing parameters at baseline are
further compounded by significantly higher indices of
left ventricular load (mean and end systolic blood
pressures). These abnormal indices, which are in
keeping with the findings of other investigators,26
represent the pressure against which the heart pumps
and are due to increased peripheral wave reflection.
They represent a greater myocardial haemodynamic
load and thus a greater need for myocardial blood
flow. This leads to a decrease in myocardial blood
Peripheral and Central Arterial Haemodynamic Interactions 157flow reserve and is a normal feature of ageing but is
accentuated by the tachycardia found in smokers.
The central mean diastolic pressure was significantly
elevated in smokers and may represent a compensa-
tory mechanism whereby an increase in pressure in
the ascending aorta during diastole may increase cor-
onary blood flow to compensate for shorter diastole. It
is of interest to note that individuals with diastolic
dysfunction have longer ejection durations and
shorter diastolic periods, as was found in these
smokers.27,28
The AAI was significantly higher in the smokers
implying that peripheral waves arrive earlier. This
greater degree of augmentation in smokers is due to
increased generation of reflected waves from vasocon-
stricted microvasculature, decreased vessel compli-
ance, or a combination of both. It occurs early in the
cardiac cycle during systole and thus results in
increased myocardial load, mean systolic pressure
and end systolic pressure. Thus even in the absence
of mural disease and structural narrowing of coronary
circulation the increased ventricular load and decrease
in perfusion may result in adverse cardiac myocyte
functioning and structure.30,31
CPT effects on peripheral and central haemodynamic
parameters
The finding that CPT had no effect on heart rate is in
keeping some previous studies32 and not with
others.33 The study investigator was known to the
subjects, and the temperature of the water bath was
not below 4 C, thus preventing a pain response. These
factors may have prevented a systemic adrenergic
response.
The response of smokers to CPT is an increase in
blood pressure at both 1 and 3 min in ice. In non-
smokers again the response at 1 min is an increase in
blood pressure. The magnitude of blood pressure
increase in the smokers is less than that of the non-
smoker and is in keeping with higher resting tone in
the smokers. This is possibly a result of decreased
endothelial constitutive nitric oxide synthase
(ecNOS) release or production in the smoker and sub-
sequent over-riding constriction. This is consistent
with previous work from this department of conduit
vessel function using brachial artery ultrasound,
which demonstrated arterial constriction in smokers
following CPT (unpublished observations).
Surprisingly, the differential of the pressure wave
(dP/dt), used to determine AAI, is significantly
decreased in non-smokers after the CPT (Fig. 1).
We have demonstrated previously in non-smokersthat conduit vessels at 1 min following CPT are
seen to dilate and by 3 min they have constricted
(unpublished observations). These changes at 1 min
may not be accounted for by microvascular dilatation
as laser Doppler flowmetry studies of skin micro-
circulation have shown vasoconstriction to occur
initially.32,34±36 This early dilatation may allow for
increased absorption of reflected waves and may
represent an endothelial protective mechanism to a
physiological stress that uncouples the left ventricle
from a potential sudden increase in load. It is conceiv-
able that signalling between the micro and macro-
circulation induces this to absorb the impact of
microvascular vasoconstriction and the central pres-
sure changes that we have observed in both groups.
In the case of the smoker, absolute values of dP/dt
are non-significantly increased at 1 min but clinically
suggest an increase in peripheral wave reflection.
However, when compared to non-smokers there is a
significant difference in the direction of change at
1 min. At 3 min these changes are not significantly
different perhaps reflecting a degree of accommodation
to the stress (Fig. 1).
It is possible that the vasoactive effects of smoking,
on the macro and microcirculation, mask a differential
response of the endothelium in the two vascular beds.
These changes may reflect basal NO availability in
both conduit vessels and microvascular beds. How-
ever, in the microvasculature the endothelium may be
activated by the pro-inflammatory properties of smok-
ing. It has been previously shown that inducible nitric
oxide synthase (iNOS) can modulate monocyte
and endothelial cell activation in an autocrine and
paracrine fashion and it may react with superoxide
anion to form the potent oxidant and inhibitor of
nitric oxide, peroxynitrite.37,38 The resultant increase
in NO from iNOS may lead to a down regulation
of endothelial constitutive nitric oxide synthase
(ecNOS) activity and thus regulation of microvascular
vasodilatatory tone.39
In summary, this study recognises that smoking
upsets complex haemodynamic mechanisms even in
young smokers with a resultant increase in myocar-
dial workload and a decreased capacity for coronary
perfusion. The important observations include an
increase in blood pressure in non-smokers at 1 and
3 min in ice and a lesser magnitude of blood pressure
response in smokers, perhaps representing a higher
resting vascular tone in smokers due to decreased
availability of NO. We have previously demonstrated
a differential release of NO from monocytes in
the macro and microcirculation (unpublished
observations). The interaction between the monocyte,
or other inflammatory cells, and both resistanceEur J Vasc Endovasc Surg Vol 25, February 2003
158 F. Fennessy et al.and conduit endothelial vascular beds may well be the
key. Modulation of NO availability may be desirable
to decrease atherogenesis and improve overall
cardiovascular dynamics.
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